High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis-Reference-Cited by-同舟云学术

High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis

Published:2016-08 Issue:2 Volume:150 Page:299-306
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Hoffmann-Vold Anna-Maria,Tennøe Anders Heiervang,Garen Torhild,Midtvedt Øyvind,Abraityte Aurelija,Aaløkken Trond Mogens,Lund May Britt,Brunborg Cathrine,Aukrust Pål,Ueland Thor,Molberg Øyvind

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference31 articles.

1. Pathogenesis of systemic sclerosis;Pattanaik;Front Immunol,2015

2. Systemic sclerosis;Allanore,2012

3. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database;Tyndall;Ann Rheum Dis,2010

4. Mortality and survival in systemic sclerosis: systematic review and meta-analysis;Rubio-Rivas;Semin Arthritis Rheum,2014

5. Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis;Hoffmann-Vold;J Rheumatol,2013

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic sclerosis-associated interstitial lung disease: Diagnostic approaches and challenges;Revista Colombiana de Reumatología (English Edition);2024-04

2. Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention;Life;2024-02-06

3. Dynamic shifts in lung cytokine patterns in post-COVID-19 interstitial lung disease patients: a pilot study;Therapeutic Advances in Chronic Disease;2024-01

4. Intercellular Communication and Epigenetic State of Ligand-Receptor Pairs in Systemic Sclerosis-Associated Interstitial Lung Disease;2024

5. Biomarkers in Systemic Sclerosis;Scleroderma;2024